SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-18-329055
Filing Date
2018-11-16
Accepted
2018-11-16 16:54:47
Documents
2
Effectiveness Date
2018-11-16

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 d636069ds8pos.htm S-8 POS 33731
2 EX-23.3 d636069dex233.htm EX-23.3 1725
  Complete submission text file 0001193125-18-329055.txt   36668
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-227179 | Film No.: 181190416
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences